-PXMD Strengthened Executive Team and Board of Directors With Recent Appointments After IPO in August 2022- -Phase 3 Results for HAT-301 Trial Expected in First Half 2023- TARRYTOWN, NY, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the… Read More..

Conference Call Tuesday, November 15, 2022 at 10:30am EST / 9:30am CST DALLAS, November 15, 2022--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX), ("Blackbox" or the "Company"), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results… Read More..

Providing Forward Looking Guidance on User Metrics and Revenue for the First Time as the Company Transitions From Pre-Revenue to Revenue Generating in 2023 Investor Call and Webcast at 10:30 AM ET Today BOULDER, CO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia Inc. (NASDAQ: AUUD) (NASDAQ: AUUDW)… Read More..